Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.

NCT01825577 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT01825577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01825577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.
Lead sponsor
St. Louis University
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2012
Completion date
February 28, 2015
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accidental falls, apathy, dementia